WO2007013426A1 - 発酵乳の製造方法及び発酵乳飲食品 - Google Patents
発酵乳の製造方法及び発酵乳飲食品 Download PDFInfo
- Publication number
- WO2007013426A1 WO2007013426A1 PCT/JP2006/314622 JP2006314622W WO2007013426A1 WO 2007013426 A1 WO2007013426 A1 WO 2007013426A1 JP 2006314622 W JP2006314622 W JP 2006314622W WO 2007013426 A1 WO2007013426 A1 WO 2007013426A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fermented milk
- protease
- lactic acid
- pro
- casein
- Prior art date
Links
- 235000015140 cultured milk Nutrition 0.000 title claims abstract description 96
- 235000013305 food Nutrition 0.000 title claims abstract description 33
- 238000000034 method Methods 0.000 title claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 title claims description 34
- 235000013361 beverage Nutrition 0.000 title abstract description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 105
- 239000004365 Protease Substances 0.000 claims abstract description 81
- 108091005804 Peptidases Proteins 0.000 claims abstract description 62
- 241000894006 Bacteria Species 0.000 claims abstract description 54
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 52
- 239000004310 lactic acid Substances 0.000 claims abstract description 52
- 235000019419 proteases Nutrition 0.000 claims abstract description 52
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 48
- 239000005018 casein Substances 0.000 claims abstract description 37
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 37
- 235000021240 caseins Nutrition 0.000 claims abstract description 37
- 235000020244 animal milk Nutrition 0.000 claims abstract description 31
- 108090000526 Papain Proteins 0.000 claims abstract description 9
- 235000019834 papain Nutrition 0.000 claims abstract description 9
- 229940055729 papain Drugs 0.000 claims abstract description 9
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract 11
- 102000035195 Peptidases Human genes 0.000 claims description 51
- DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 claims description 49
- 108010015385 valyl-prolyl-proline Proteins 0.000 claims description 29
- 238000000855 fermentation Methods 0.000 claims description 23
- 230000004151 fermentation Effects 0.000 claims description 23
- RWCOTTLHDJWHRS-YUMQZZPRSA-N Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RWCOTTLHDJWHRS-YUMQZZPRSA-N 0.000 claims description 19
- 108010004032 Bromelains Proteins 0.000 claims description 18
- 230000007515 enzymatic degradation Effects 0.000 claims description 17
- 239000000047 product Substances 0.000 claims description 17
- 108010077112 prolyl-proline Proteins 0.000 claims description 16
- 235000019835 bromelain Nutrition 0.000 claims description 15
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 14
- 235000009467 Carica papaya Nutrition 0.000 claims description 8
- 239000007857 degradation product Substances 0.000 claims description 8
- 241000186660 Lactobacillus Species 0.000 claims description 7
- VNYDHJARLHNEGA-RYUDHWBXSA-N Tyr-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 VNYDHJARLHNEGA-RYUDHWBXSA-N 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 claims description 7
- 108010020532 tyrosyl-proline Proteins 0.000 claims description 7
- 240000006432 Carica papaya Species 0.000 claims description 5
- 230000000593 degrading effect Effects 0.000 claims description 4
- 238000006911 enzymatic reaction Methods 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 229940013712 pineapple extract Drugs 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 abstract description 18
- 235000019634 flavors Nutrition 0.000 abstract description 18
- 230000003276 anti-hypertensive effect Effects 0.000 abstract description 3
- 230000005714 functional activity Effects 0.000 abstract 2
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 abstract 2
- 239000007859 condensation product Substances 0.000 abstract 1
- 230000035622 drinking Effects 0.000 abstract 1
- 102000011632 Caseins Human genes 0.000 description 31
- 108010076119 Caseins Proteins 0.000 description 31
- 230000000052 comparative effect Effects 0.000 description 27
- JREYOWJEWZVAOR-UHFFFAOYSA-N triazanium;[3-methylbut-3-enoxy(oxido)phosphoryl] phosphate Chemical compound [NH4+].[NH4+].[NH4+].CC(=C)CCOP([O-])(=O)OP([O-])([O-])=O JREYOWJEWZVAOR-UHFFFAOYSA-N 0.000 description 19
- 102000004190 Enzymes Human genes 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 230000004531 blood pressure lowering effect Effects 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 11
- 230000036772 blood pressure Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 235000020183 skimmed milk Nutrition 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 241000234671 Ananas Species 0.000 description 6
- 235000007119 Ananas comosus Nutrition 0.000 description 6
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 6
- CGSOWZUPLOKYOR-AVGNSLFASA-N Pro-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 CGSOWZUPLOKYOR-AVGNSLFASA-N 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000013365 dairy product Nutrition 0.000 description 5
- 235000013376 functional food Nutrition 0.000 description 5
- 235000019833 protease Nutrition 0.000 description 5
- 240000002605 Lactobacillus helveticus Species 0.000 description 4
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 229940054346 lactobacillus helveticus Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 240000006439 Aspergillus oryzae Species 0.000 description 3
- 241000219173 Carica Species 0.000 description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 235000020124 milk-based beverage Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 108090000886 Ananain Proteins 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 101000613603 Carica papaya Papaya proteinase 4 Proteins 0.000 description 1
- 108090000391 Caricain Proteins 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 108090001069 Chymopapain Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CMHTUJQZQXFNTQ-OEAJRASXSA-N Phe-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O CMHTUJQZQXFNTQ-OEAJRASXSA-N 0.000 description 1
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 1
- WHNJMTHJGCEKGA-ULQDDVLXSA-N Pro-Phe-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O WHNJMTHJGCEKGA-ULQDDVLXSA-N 0.000 description 1
- 101710180012 Protease 7 Proteins 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229960002976 chymopapain Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 235000021247 β-casein Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
- A23C9/1209—Proteolytic or milk coagulating enzymes, e.g. trypsine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
- A23C9/1275—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss using only lactobacteriaceae for fermentation in combination with enzyme treatment of the milk product; using enzyme treated milk products for fermentation with lactobacteriaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
Definitions
- the present invention can efficiently produce peptides such as Val Pro Pro, lie Pro Pro, and Tyr Pro, which have been confirmed to have useful functions such as blood pressure lowering action, in fermented milk.
- the present invention relates to a method for producing fermented milk that can be easily imparted with excellent flavor and the like that can be used as a food and drink, and a fermented milk food and drink that uses fermented milk obtained by the method. Background art
- peptides that exhibit useful functions such as blood pressure lowering effects have been separated and reported from enzymatic degradation products of food proteins and fermented foods.
- a peptide having a Pro residue at the carboxy terminus may exert a blood pressure lowering effect in vivo because there are many so-called angiotensin converting enzyme (ACE) inhibitory activities that regulate blood pressure in vivo. It is shown.
- ACE angiotensin converting enzyme
- Patent Document 1 describes a method in which a milk component is produced by fermentation with lactic acid bacteria such as Lactobacillus helveticus.
- Patent Documents 2 to 4 propose methods for producing main milk protein casein by enzymatic degradation.
- the functional peptide can be efficiently produced by appropriately setting the amount and conditions of the enzyme used.
- a functional peptide obtained by such enzymatic degradation is to be used in a dairy product such as a fermented milk food having a good flavor and containing the peptide at a high concentration, it is purified, concentrated, and powdered after enzymatic digestion. It is inevitable that the manufacturing process will be complicated.
- fermented milk that can be used as a food or drink or its raw material can be obtained directly, and a functional peptide is produced in the fermented milk. Therefore, the fermented milk obtained without necessarily purifying, concentrating, and pulverizing the functional peptide can be easily used for dairy products.
- Patent Document 5 proposes a specific lactic acid bacterium that can improve the productivity of a functional peptide exhibiting a blood pressure lowering action and the like, and can efficiently decompose casein, and fermented milk using the lactic acid bacterium. .
- Non-Patent Document 3 in order to obtain a blood pressure lowering effect using Val Pro Pro and lie Pro Pro as active ingredients, the effective daily dose for adults is 3.4 mg or more as a total converted value thereof. It has been reported to do.
- the effective daily dose for adults is 3.4 mg or more as a total converted value thereof. It has been reported to do.
- Patent Document 5 when producing a final product having a blood pressure lowering function containing the effective amount of peptide using fermented milk by lactic acid bacteria described in Patent Document 5, use 60 ml or more of the fermented milk. The final product needs to be manufactured.
- Patent Document 1 Japanese Patent No. 2782142
- Patent Document 2 JP-A-6_128287
- Patent Document 3 Japanese Patent Laid-Open No. 2001-136995
- Patent Document 4 Pamphlet of WO2005Z012542
- Patent Document 5 Japanese Patent No. 3028411
- Non-Patent Document 1 Nakamura et al. J. Dairy Sci. 78: pl253-1257 (1995)
- Non-Patent Document 2 Yamamoto et al. J. Dairy Sci. 82: pl388_1393 (1995)
- Non-Patent Document 3 Hata et al. Am J. Clin. Nutr., P767-771 (1996) Disclosure of the invention
- a problem of the present invention is that a specific peptide having a useful function such as a blood pressure lowering effect can be efficiently produced in fermented milk, and the fermented milk food and drink have excellent flavor and blood pressure lowering.
- An object of the present invention is to provide a fermented milk production method capable of easily imparting functionalities such as action and the like, and a fermented milk food and drink that uses the fermented milk and has excellent flavor and functionality.
- the step (A) of enzymatically degrading animal milk casein with a protease (1) comprising at least one protease belonging to superfamily that exhibits papain, bromelain and similar enzyme reactions, , Animal milk casein and / or the enzymatic degradation product of animal milk casein by the above-mentioned protease (1) in combination with the step (B) of fermenting lactic acid bacteria, Val Pro Pro (hereinafter sometimes abbreviated as VPP), lie Provided is a method for producing fermented milk, characterized by producing at least one of Pro Pro (hereinafter sometimes abbreviated as IPP) and Tyr Pro (hereinafter sometimes abbreviated as YP).
- a protease (1) comprising at least one protease belonging to superfamily that exhibits papain, bromelain and similar enzyme reactions, , Animal milk casein and / or the enzymatic degradation product of animal milk casein by the above-mentioned protease (1) in combination with the step (B
- animal milk casein animal milk having a casein concentration of about 10 to 10% by weight is used, and the addition amount of the protease (1) is 0.005 to the amount of casein.
- Fermented milk food and drink containing fermented milk or its concentrate obtained at ⁇ 0.1% by weight, Val Pro Pro 1.2mgZl00ml or more, lie Pro Pro l.Omg / lOOml or more and Ding 1 ⁇ 1 "
- a fermented milk food or drink characterized by containing 0.5113 ⁇ 4 / 1001111 or more of 0 .
- the method for producing fermented milk of the present invention combines the steps (A) and (B), a specific peptide having a useful function such as a blood pressure lowering effect is efficiently contained in the fermented milk. It can be produced well. Moreover, it is possible to easily impart excellent flavor and functionality such as a blood pressure lowering effect to fermented milk foods and drinks. In particular, by simultaneously performing the steps (A) and (B), the production step can be simplified and the production efficiency of the specific peptide can be improved.
- the fermented milk food and drink of the present invention has a useful function obtained by the production method of the present invention. Since fermented milk containing a large amount of the specific peptide to be used is used, it is possible to obtain a fermented milk food and drink that is easy to adjust in flavor, excellent in flavor, and capable of imparting functionality.
- FIG. 1 is a graph showing the production amounts of VPP and IPP peptides according to the difference in the amount of bromelain added in Example 4.
- the production method of the present invention includes a step (A) of enzymatic degradation of animal milk casein with a specific protease (1).
- the specific protease (1) includes at least one of a protease belonging to a superfamily that exhibits nopain, bromelain, and similar enzyme reactions.
- the protease (1) exhibits a specificity to ⁇ -casein having peptide sequences such as VPP, IPP, YP, etc., and is considered to be deficient in the initial degradation of animal milk casein in normal lactic acid bacteria fermentation. It includes proteases that can complement and enhance activity and increase the production rate of peptides with the desired functionality.
- the protease belonging to the superfamily showing papain, bromelain and similar enzyme reaction is usually (Xaa) m Val Pro Pro (Xbb) n, (Xaa) mlie Pro Pro (Xb b) n or It includes a protease that cleaves at least one of the peptides represented by (Xaa) m Tyr Pro (Xbb) n at the carboxyl terminus of (Xaa) m.
- Xaa and Xbb independently represent any amino acid.
- Xaa in one of the peptide sequences may be the same or different from Xaa in the other peptide sequence
- Xbb in one of the peptide sequences may be the same or different from Xbb in the other peptide sequence.
- m and n are integers, and when m is 2 or more, Xaa may be the same or different. When n is 2 or more, Xbb may be the same or different.
- papain a papaya extract can be used, and as a bromelain, a pineapple paste can be used.
- protease belonging to the superfamily examples include ananain, ananase, extranase, pinase, and pineapple.
- Norre 'Enzaimu pineapple enzyme
- Toraumana 1 - i toraumanase
- Nono Haiyochin papayo tin
- Sumetorin summetrin
- Bae Funoredon velardon input Nono Hire' to Fuchidaze
- papaya pe ptiaase liver Nononono down, chymopapain
- ⁇ ⁇ ⁇ 7 ⁇ Floor Ina 1 to i papaya proteinase
- PPIV potashin
- protease 'omega proteinase omega
- CI peptidase examples include ananain, ananase, extranase, pinase, and pineapple.
- Norre 'Enzaimu pineapple enzyme
- Plant cysteine peptidases having cysteine at the active center as mentioned above, and proteases belonging to the subfamily of papain are particularly preferred. Also included are cathep sin and the like, which have a very high homology between these enzymes and the active center and appear to have similar substrate specificity.
- the protease (1) used in the step (A) may be a mixture of a plurality of enzymes, or may contain a specific protease other than those described above for the purpose of improving degradability.
- protease (1) Commercially available products can also be used as protease (1).
- trade name Papain F Al Enzyme
- trade name VERON L10 Higuchi Shokai
- trade name Bromelain Great Food Co., Ltd.
- the product name Papain W_40 manufactured by Amano Enzyme Co., Ltd.
- the refined food nopain manufactured by Nagase ChemteX Corporation
- the animal milk casein used in step (A) or step (B) to be described later is a food material containing animal milk casein having VPP, IPP, and YP peptide sequences having functions such as blood pressure lowering action.
- animal milk such as cow milk, skim milk powder, processed milk, and animal milk casein extract, as well as food materials added with lactic acid bacteria fermentation aids such as vitamins, nucleic acids, and yeast extract. .
- the casein concentration is not particularly limited, but is usually about 3 to 15% by weight, preferably 3 in order to obtain the desired effect of the present invention more efficiently. ⁇ 10% by weight.
- the amount of protease (1) to be used can be appropriately determined in consideration of the titer so as to have a desired effect, but it is combined with lactic acid bacteria fermentation in step (B) described later. Therefore, the objective can be achieved with a smaller amount of use than when enzymatically degrading animal milk casein with protease alone.
- the protease (1) is preferably in a proportion of 0.005 to 0.1% by weight based on the amount of animal milk casein. Below 0.005% by weight, the desired of the present invention There is a possibility that the effect cannot be obtained, and when it exceeds 0.1% by weight, the amount of the peptide to be produced becomes excessive and there is a risk that the flavor will be lost.
- the enzymatic degradation conditions can be carried out at the optimum temperature and pH of the protease (1), usually at 25 to 45 ° C. while maintaining the pH at a neutral level.
- the enzyme degradation time can be appropriately selected according to the amount and titer of protease (1).
- step (A) When the step (A) is performed prior to the step (B) described later, the protease (1) is deactivated at about 60-100 ° C after the enzymatic decomposition, and then the step (B) Can be used.
- step (A) is carried out at the same time as step (B) described later, that is, in cases where animal milk casein is enzymatically degraded and lactic acid bacteria fermented in a medium containing both the protease (1) and lactic acid bacteria, 25 It is preferable to adjust to the optimal growth condition temperature of lactic acid bacteria at ⁇ 45 ° C., and the fermentation time of lactic acid bacteria is usually 5-30 hours. At this time, the fermentation time can be shortened by increasing the amount of enzyme added.
- the production method of the present invention comprises animal milk casein and / or the above-mentioned proteaase of animal milk casein (
- step (B) of fermenting the enzymatic degradation product according to 1) with lactic acid bacteria Including the step (B) of fermenting the enzymatic degradation product according to 1) with lactic acid bacteria.
- step (B) The animal milk casein described above can be used as the animal milk casein used in the step (B).
- the process (A) and the process (B) are simultaneously performed as described above.
- step (B) can be performed after step (A) is completed.
- lactic acid bacteria used in the step (B) include lactic acid bacteria belonging to the genus Streptococcus, Ratatococcus, Ratatobacillus, Bifidobacterium, etc., with the genus Lactobacillus being preferred.
- Lactobacillus bulgaricus Lactobacillus helveticus, Lactobacillus casei, Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus acidophilus Lactobacillus fermentum, etc., especially ratatobatorenoles helveticas or lactobacillus acidophilus, lactobacillus bulgaricus, lactobacillus caseica VPP, IPP, YP more efficiently
- two or more of these can be used.
- the Lactobacillus helveticus strain includes an extracellular proteinase activity. A high one is preferred. For example, according to the method of Twinmoto et al. (Twining, S. Anal. Biochem. 143 3410 (1984), Yamamoto et al. (Yamamoto, Tsuji et al. J. Biochem. (1993) 114, 740)) A strain having a value of UOOD590 of OO or higher is preferred.
- CM4 Lactobacillus' Helveticas CM4 strain (Incorporated administrative agency, National Institute of Advanced Industrial Science and Technology, Patent Biological Deposit Center, Ibaraki Prefecture Tsukuba Rinto Central 6th Deposit Number: FERM BP_6060, Deposit Date 1997.8.15X or less, referred to as CM4) Is mentioned.
- This CM4 is registered with the above deposit number in the Budapest Treaty concerning the international recognition of microbial deposits under patent procedures, and this strain has already been patented.
- the lactic acid bacteria are preferably used as a starter having a sufficiently high activity and pre-cultured beforehand.
- the initial bacterial count is preferably about 10 5 to 10 9 cells / ml.
- the step (B) can be performed using yeast in combination with the lactic acid bacteria.
- the strain of yeast is not particularly limited, and preferred examples include Saccharomyces yeasts such as Saccharomyces cerevisiae.
- the content ratio of yeast can be appropriately selected depending on the purpose.
- lactic acid bacteria fermentation adjuvants can be added.
- the adjuvant include amino acids, vitamins, minerals, nucleic acids, salts, microbial sex, and detergent agents.
- step (B) the fermentation conditions for lactic acid bacteria are usually 25 to 45 ° C, depending on the optimal growth temperature for lactic acid bacteria, whether it is performed simultaneously with step (A) or after step (A). Usually, it is preferable to carry out under conditions of 5 to 30 hours. In addition, neutralization culture is preferable for the purpose of promoting fermentation.
- fermented milk containing more of any of VPP, IPP, and YP can be obtained than only ordinary lactic acid bacteria fermentation without performing step (A).
- step (ii) since the step (ii) is included, a product containing a peptide such as VPP, IPP, or YP can be obtained directly as fermented milk.
- step (B) is performed after step (A) or steps (A) and (B) are performed simultaneously, at least one of VPP, IPP, and YP is produced more than lactic acid bacteria fermentation alone.
- the fermented milk food / beverage product of the present invention may be used as the animal milk casein in the production method.
- Fermented milk or concentrate thereof obtained by using animal milk with a concentration of zein of 3 ⁇ 4 to 10% by weight, and an amount of the added amount of protease (1) of 0.005 to 0.1% by weight based on the amount of casein Fermented milk foods and beverages containing VPP 1.2mgZl00ml or more, IPP l.OmgZlOOml or more and YP 0.5mg / l00ml or more.
- the measurement of the amount of a specific peptide contained is one for easily evaluating more types of peptides than the power that can be measured by various HPLC methods.
- the LCZMS method is used as the method.
- the LCZMS analysis method the method already reported by Matsuura et al. (MilchBib, 2004, 60, 24-27) is used.
- the fermented milk food and drink of the present invention uses the fermented milk obtained by the production method of the present invention or a concentrated product thereof.
- yogurt, lactic acid bacteria drinks, dairy lactic acid bacteria drinks, and other various processed products It can be a milk food or drink, and can be in the form of a room temperature milk drink, a chilled milk drink, a general food, a dietary supplement, or the like.
- supplemental additives can be added to the fermented milk food and drink according to the present invention from the viewpoint of improving nutritional balance and flavor according to the form.
- carbohydrates, lipids, vitamins, minerals, nutritional additives, sweeteners, fragrances, pigments, texture improvers and the like can be mentioned.
- the fermented milk food and drink of the present invention contains a specific peptide known to exhibit a blood pressure lowering effect such as VPP, IPP and YP, functional food and drink such as food for specified health use, It can also be set as the functional food-drinks which displayed the effect for blood pressure lowering effect.
- the amount of each intake is usually O. lmlZkg body weight as the amount of fermented milk contained. -5.0 ml / kg body weight, particularly preferably 0.3 ml / kg body weight to 0.6 ml / kg body weight.
- CM4 was sterilized at 100 ° C in a milk medium consisting of skim milk powder with a solid content of 9% by weight 37 Pre-culture at 20 ° C. for 20 hours to prepare a lactic acid bacteria starter. Next, to the newly prepared 30% skim milk powder of 9% by weight, the starter was added to 3% by weight.
- Example 1 the product name Papain F (manufactured by Amano Enzym, Carica papaya L.), in Example 2, the trade name purified papain (manufactured by Nagase Seikagaku, Carica papaya), and in Example 3, trade name Bromelain F (Amano Enzym, Ananas comosus ⁇
- Example 1 the trade name Protease ⁇ (Amano Enzyme, Aspergillus oryzae) is used.
- Comparative Example 2 the trade name Protease A (Amano Enzyme, Aspergillus oryza e) is used.
- the trade name Neulase F3G (manufactured by Amano Enzym Co., Rhizopus n iveus) is used. (New Japan Manabu Kogyo Co., Ltd., the Aspe rgillus oryzae-derived), were respectively 0.5mg added separately.
- the fermented milk of Comparative Examples 1 to 5 combined with protease, which does not contain the specific protease used in the present invention is significantly more VPP and IPP than the fermented milk of Comparative Example 6 using only CM4 strain lactic acid bacteria.
- the production amount of was low.
- the fermented milks of Comparative Examples 1, 2 and 5 using aspergillus-derived proteases, which are known to have the ability to produce animal milk casein, VPP and IPP were also found in VPP and IPP.
- the production amount of was extremely small.
- VPP and IPP production was not observed.
- Fermented milk was prepared in the same manner as in Example 3 except that the amount of bromelain in protease was changed to 0.1 mg, 0.25 mg, and l.Omg, and the amounts of VPP and IPP peptides were analyzed in the same manner as in Example 3. It was. The results are shown in Figure 1.
- FIG. 1 also shows the result of Example 3 in which the amount of bromelain of protease was 0.5 mg and the result of Comparative Example 6 in which no protease was added.
- Each left bar in Figure 1 shows the VPP content, and each right bar shows the IPP content.
- the addition of 0.1, 0.25, 0.5, and 1 mg bromelain to 30 ml of fermented milk means that 0.008%, 0.021%, and 0.042% by weight of protease for the amount of casein in fermented milk, respectively. And 0.084% by weight.
- Figure 1 confirms that the productivity of both peptides is improved when added compared to when bromelain is not added.
- the amount of protease added was in the range of 0.25 to 1.0 mg, it was confirmed that the productivity of VPP and IPP peptides was about 1.5 times that of unadded force.
- CM4 was pre-cultured at 37 ° C. for 24 hours in a milk medium consisting of skim milk powder having a solid content of 9% by weight sterilized at 95 ° C. to prepare a lactic acid bacteria starter.
- the starter was added to 1 liter of a newly prepared milk medium consisting of skim milk powder having a solid content of 9% by weight so that the starter would be 3% by weight.
- the trade name Bromelain F (Amano) 10 mg of Ananas comosus M. manufactured by Enzym Co.) was added.
- skim milk powder to which only a lactic acid bacterium starter not supplemented with protease was added was prepared. Next, each was kept at 32 ° C. for 20 hours, and enzymatic fermentation and lactic acid bacteria fermentation or lactic acid bacteria fermentation alone were carried out to prepare each fermented milk.
- the fermented milk beverage containing about 60% by weight of fermented milk of Example 5 fermented with bromelain contained 8.4 mg of tripeptide in 120 g when calculated in the same manner.
- the fermented milk beverage with a blend of about 30% by weight of the fermented milk of Example 5 was the same, while 1.9 mg of tripeptide was contained in 120 g.
- it contained 4.3 mg of tripeptide in 120 g.
- the production of YP which has been confirmed to lower blood pressure in animal studies, was also confirmed.
- Example 10 Even if it is about half of the 60% by weight product in Example 10, the effective minimum amount can be cleared with 120g product. Moreover, when the flavor evaluation of the fermented milk itself prepared in Example 5 and Comparative Example 10 was performed, there was no significant difference in flavor between the addition and non-addition of protease.
- Val Pro Pro Phe Leu and lie Pro Pro Leu Thr lactic acid bacteria species different from Lactobacillus' Helveticus are found in Val Pro Pro and lie
- the strains are Lactobacillus bulgaricus JCM1002 (RIKEN BioResource Center, Microbial Materials Development Office, 2-1) The same as above was used.
- Val Pro Pro and lie Pro Pro were produced in all strains. Therefore, Val Pro Pro Phe Leu and lie Pro Pro Leu Thr were combined with a protease that produces casein.
- the fermented milk of the lactic acid bacteria can be expected to contain Val Pro Pro and lie Pro Pro, and it can be seen that the lactic acid bacteria used are not limited to Lactobacillus helveticus.
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006800343096A CN101272693B (zh) | 2005-07-26 | 2006-07-25 | 发酵乳的制造方法和发酵乳饮料食品 |
BRPI0613979-5A BRPI0613979A2 (pt) | 2005-07-26 | 2006-07-25 | processo para a produção de leite fermentado e bebida/alimento feito a partir de leite fermentado |
JP2007528464A JP5681341B2 (ja) | 2005-07-26 | 2006-07-25 | 発酵乳の製造方法及び発酵乳飲食品 |
AU2006273395A AU2006273395B2 (en) | 2005-07-26 | 2006-07-25 | Process for production of fermented milk and fermented milk beverage/food |
US11/996,854 US20100151080A1 (en) | 2005-07-26 | 2006-07-25 | Process for production of fermented milk and fermented milk beverage/food |
CA002616789A CA2616789A1 (en) | 2005-07-26 | 2006-07-25 | Process for production of fermented milk and fermented milk beverage/food |
EP06781534A EP1908354A4 (en) | 2005-07-26 | 2006-07-25 | PROCESS FOR THE PRODUCTION OF FERMENTED MILK AND BEVERAGE / FOOD PRODUCT FOR FERMENTED MILK |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005-216037 | 2005-07-26 | ||
JP2005216037 | 2005-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007013426A1 true WO2007013426A1 (ja) | 2007-02-01 |
Family
ID=37683322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/314622 WO2007013426A1 (ja) | 2005-07-26 | 2006-07-25 | 発酵乳の製造方法及び発酵乳飲食品 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100151080A1 (ja) |
EP (1) | EP1908354A4 (ja) |
JP (1) | JP5681341B2 (ja) |
KR (1) | KR20080040683A (ja) |
CN (1) | CN101272693B (ja) |
AU (1) | AU2006273395B2 (ja) |
BR (1) | BRPI0613979A2 (ja) |
CA (1) | CA2616789A1 (ja) |
MY (1) | MY150690A (ja) |
TW (1) | TWI395552B (ja) |
WO (1) | WO2007013426A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008123095A1 (ja) * | 2007-03-27 | 2008-10-16 | Calpis Co., Ltd. | 心不全予防剤 |
JP2008283948A (ja) * | 2007-05-15 | 2008-11-27 | Bhn Kk | 乳発酵物の製造方法 |
WO2009065862A1 (en) * | 2007-11-23 | 2009-05-28 | Dsm Ip Assets B.V. | Improved bioactive peptide production |
JP2011514164A (ja) * | 2008-03-17 | 2011-05-06 | ジボダン エス エー | 酵素的プロセス |
CN102771557A (zh) * | 2012-08-10 | 2012-11-14 | 光明乳业股份有限公司 | 一种含功能性水解蛋白肽乳饮料及其制备方法 |
JP2016146775A (ja) * | 2015-02-12 | 2016-08-18 | 京都府 | 乳酸菌およびそれを用いた乳製品乳酸菌飲料の製造方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2725611A1 (en) | 2008-06-12 | 2009-12-17 | Nestec S.A. | Lactobacillus helveticus strains for producing hypotensive peptides |
CN103704788A (zh) * | 2013-12-30 | 2014-04-09 | 徐州绿之野生物食品有限公司 | 一种发酵银杏粉及加工方法 |
CN104522819B (zh) * | 2015-01-19 | 2016-08-03 | 中国食品发酵工业研究院 | 一种菠萝发酵制品及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0328411B2 (ja) | 1980-10-27 | 1991-04-19 | Emery Industries Inc | |
JPH06128287A (ja) | 1991-11-07 | 1994-05-10 | Nisshin Flour Milling Co Ltd | ペプチドおよびその製造方法 |
JP2782142B2 (ja) | 1992-07-23 | 1998-07-30 | カルピス株式会社 | アンジオテンシン変換酵素阻害剤及びその製造法 |
WO1999016862A1 (fr) * | 1997-09-26 | 1999-04-08 | Calpis Co., Ltd. | Bacterie du genre lactobacillus helveticus ayant une grande capacite de production de tripeptides, produit laitier fermente et son procede de preparation |
WO1999016461A1 (fr) * | 1997-09-26 | 1999-04-08 | Calpis Co., Ltd. | Agents antistress et aliments fonctionnels |
JP2001136995A (ja) | 1999-11-11 | 2001-05-22 | Calpis Co Ltd | トリペプチドの製造方法 |
WO2005012542A1 (ja) | 2003-08-01 | 2005-02-10 | Calpis Co., Ltd. | カゼイン加水分解物、その製造法及びその用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1941415A (en) * | 1932-07-30 | 1933-12-26 | Res Lab Of Nat Dairy Products | Method of treating milk and milk products to recover the contained milkfat in substantially pure and neutral condition |
US4172900A (en) * | 1975-07-17 | 1979-10-30 | Kraft, Inc. | Natural cheese of intensified flavor |
CH635483A5 (en) * | 1978-12-04 | 1983-04-15 | Nestle Sa | Process for the manufacture of a drink with yoghurt taste |
CN1053730A (zh) * | 1990-12-24 | 1991-08-14 | 北京大学 | 酶法母乳化牛乳粉的制造方法 |
DK1142481T4 (da) * | 1999-01-11 | 2009-12-21 | Calpis Co Ltd | Fremgangsmåde til fremstilling af fermenteret mælk indeholdende et peptid, der inhiberer et angiotensinomdannende enzym og fremgangsmåde til fremstilling af mælkeserum |
CN1459235A (zh) * | 2003-04-03 | 2003-12-03 | 石家庄三鹿集团股份有限公司 | 婴儿奶粉及其生物技术生产方法 |
AU2004237455B2 (en) * | 2003-05-05 | 2007-08-02 | Dsm Ip Assets B.V. | Hydrolysed casein product comprising tripeptides IPP and/ or VPP |
-
2006
- 2006-07-25 JP JP2007528464A patent/JP5681341B2/ja not_active Expired - Fee Related
- 2006-07-25 WO PCT/JP2006/314622 patent/WO2007013426A1/ja active Application Filing
- 2006-07-25 KR KR1020087002410A patent/KR20080040683A/ko not_active Application Discontinuation
- 2006-07-25 BR BRPI0613979-5A patent/BRPI0613979A2/pt not_active IP Right Cessation
- 2006-07-25 CN CN2006800343096A patent/CN101272693B/zh not_active Expired - Fee Related
- 2006-07-25 US US11/996,854 patent/US20100151080A1/en not_active Abandoned
- 2006-07-25 AU AU2006273395A patent/AU2006273395B2/en not_active Ceased
- 2006-07-25 CA CA002616789A patent/CA2616789A1/en not_active Abandoned
- 2006-07-25 EP EP06781534A patent/EP1908354A4/en not_active Withdrawn
- 2006-07-26 MY MYPI20063595 patent/MY150690A/en unknown
- 2006-07-26 TW TW095127350A patent/TWI395552B/zh not_active IP Right Cessation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0328411B2 (ja) | 1980-10-27 | 1991-04-19 | Emery Industries Inc | |
JPH06128287A (ja) | 1991-11-07 | 1994-05-10 | Nisshin Flour Milling Co Ltd | ペプチドおよびその製造方法 |
JP2782142B2 (ja) | 1992-07-23 | 1998-07-30 | カルピス株式会社 | アンジオテンシン変換酵素阻害剤及びその製造法 |
WO1999016862A1 (fr) * | 1997-09-26 | 1999-04-08 | Calpis Co., Ltd. | Bacterie du genre lactobacillus helveticus ayant une grande capacite de production de tripeptides, produit laitier fermente et son procede de preparation |
WO1999016461A1 (fr) * | 1997-09-26 | 1999-04-08 | Calpis Co., Ltd. | Agents antistress et aliments fonctionnels |
JP2001136995A (ja) | 1999-11-11 | 2001-05-22 | Calpis Co Ltd | トリペプチドの製造方法 |
WO2005012542A1 (ja) | 2003-08-01 | 2005-02-10 | Calpis Co., Ltd. | カゼイン加水分解物、その製造法及びその用途 |
Non-Patent Citations (7)
Title |
---|
HATA ET AL., AM. J. CLIN. NUTR., 1996, pages 767 - 771 |
MATSUURA ET AL., MILCHWISSENSCHAFT, vol. 60, 2004, pages 24 - 27 |
NAKAMURA ET AL., J. DAIRY SCI., vol. 78, 1995, pages 1253 - 1257 |
TWINING, S., ANAL. BIOCHEM., vol. 143, 1984, pages 3410 |
YAMAMOTO ET AL., J. DAIRY SCI., vol. 82, 1995, pages 1388 - 1393 |
YAMAMOTO N. ET AL., J. BIOCHEM., vol. 114, 1993, pages 740 |
YAMAMOTO N.: "Ketsueki Koka Peptide Sansei ni Kanyo suru Nyusankin Tanpakushitsu Bunkai Kosokei", BIOSCIENCE AND INDUSTRY, vol. 57, no. 10, 1999, pages 667 - 672, XP003007755 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5292632B2 (ja) * | 2007-03-27 | 2013-09-18 | カルピス株式会社 | 心不全予防剤 |
WO2008123096A1 (ja) * | 2007-03-27 | 2008-10-16 | Calpis Co., Ltd. | 腎不全予防剤 |
EA016808B1 (ru) * | 2007-03-27 | 2012-07-30 | Калпис Ко., Лтд. | ПРИМЕНЕНИЕ ТРИПЕПТИДОВ Val Pro Pro И Ile Pro Pro ДЛЯ СУПРЕССИИ УТОЛЩЕНИЯ СТЕНКИ СЕРДЦА |
JP5292633B2 (ja) * | 2007-03-27 | 2013-09-18 | カルピス株式会社 | 腎不全予防剤 |
WO2008123095A1 (ja) * | 2007-03-27 | 2008-10-16 | Calpis Co., Ltd. | 心不全予防剤 |
US8673854B2 (en) | 2007-03-27 | 2014-03-18 | Calpis Co., Ltd. | Prophylactic agent for heart failure |
JP2008283948A (ja) * | 2007-05-15 | 2008-11-27 | Bhn Kk | 乳発酵物の製造方法 |
WO2009065862A1 (en) * | 2007-11-23 | 2009-05-28 | Dsm Ip Assets B.V. | Improved bioactive peptide production |
JP2011504363A (ja) * | 2007-11-23 | 2011-02-10 | ディーエスエム アイピー アセッツ ビー.ブイ. | 改良された生理活性ペプチドの生成 |
JP2011514164A (ja) * | 2008-03-17 | 2011-05-06 | ジボダン エス エー | 酵素的プロセス |
JP2014158495A (ja) * | 2008-03-17 | 2014-09-04 | Givaudan Sa | 酵素的プロセス |
CN102771557A (zh) * | 2012-08-10 | 2012-11-14 | 光明乳业股份有限公司 | 一种含功能性水解蛋白肽乳饮料及其制备方法 |
JP2016146775A (ja) * | 2015-02-12 | 2016-08-18 | 京都府 | 乳酸菌およびそれを用いた乳製品乳酸菌飲料の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101272693B (zh) | 2012-08-01 |
AU2006273395A1 (en) | 2007-02-01 |
MY150690A (en) | 2014-02-28 |
TWI395552B (zh) | 2013-05-11 |
EP1908354A1 (en) | 2008-04-09 |
CA2616789A1 (en) | 2007-02-01 |
BRPI0613979A2 (pt) | 2011-02-22 |
CN101272693A (zh) | 2008-09-24 |
JPWO2007013426A1 (ja) | 2009-02-05 |
KR20080040683A (ko) | 2008-05-08 |
JP5681341B2 (ja) | 2015-03-04 |
AU2006273395B2 (en) | 2012-10-04 |
TW200800047A (en) | 2008-01-01 |
EP1908354A4 (en) | 2011-12-28 |
US20100151080A1 (en) | 2010-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rai et al. | Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension | |
WO2007013426A1 (ja) | 発酵乳の製造方法及び発酵乳飲食品 | |
EP1226267B1 (en) | Process for producing a product containing antihypertensive tripeptides | |
Donkor et al. | Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of growth and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk | |
CN101925674A (zh) | 改进的生物活性肽生产 | |
Wang et al. | Fermentation characteristics and angiotensin I-converting enzyme–inhibitory activity of Lactobacillus helveticus isolate H9 in cow milk, soy milk, and mare milk | |
JP4525754B2 (ja) | 代謝能力が低減した微生物を用いた生物活性食品成分の保護 | |
Pihlanto et al. | Bioactive peptides from fermented foods and health promotion | |
Parmar et al. | Purification and production of novel angiotensin I-converting enzyme (ACE) inhibitory bioactive peptides derived from fermented goat milk | |
Brasca et al. | Proteolytic activity and production of γ-aminobutyric acid by Streptococcus thermophilus cultivated in microfiltered pasteurized milk | |
Hamme et al. | Crude goat whey fermentation by Kluyveromyces marxianus and Lactobacillus rhamnosus: contribution to proteolysis and ACE inhibitory activity | |
Solieri et al. | Fermentation of whey protein concentrate by Streptococcus thermophilus strains releases peptides with biological activities | |
JP2009296910A (ja) | ビフィドバクテリウム属菌含有組成物及びビフィドバクテリウム属菌含有組成物の製造方法 | |
Ale et al. | Technological role and metabolic profile of two probiotic EPS-producing strains with potential application in yoghurt: Impact on rheology and release of bioactive peptides | |
MX2012009975A (es) | Un metodo para producir un alimento fermentado que contiene bifidobacterias. | |
Ummadi et al. | Use of protein hydrolysates in industrial starter culture fermentations | |
WO2004015125A9 (en) | Process for preparing peptides with anti-hypertensive properties | |
WO2018192830A1 (en) | Process for the accelerated preparation of a fermented milk product with aid of an exopeptidase | |
US20240032553A1 (en) | Frozen enzyme pellets | |
JPH1033115A (ja) | ホエー飲料とその製造法 | |
JP2015050993A (ja) | 消化管内および糞便由来乳酸菌培養用乳もしくは豆乳由来組成物、培養用又は発酵用原料及び乳酸発酵物 | |
Fatah | Anti-hypertensive (Angiotensin converting enzyme-inhibitory) peptides released from milk proteins by proteolytic microorganisms and enzymes | |
JP2008516619A (ja) | デコイ成分による選択した生物活性食品成分の保護方法 | |
MX2008000944A (es) | Procedimiento para la produccion de leche fermentada y bebida/alimento de leche fermentada. | |
BEERMANN et al. | LACTIC ACID BACTERIA AND ASSOCIATED PRODUCT CHARACTERISTICS WITHIN MILK FERMENTATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680034309.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2008/000944 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007528464 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 2616789 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087002410 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006781534 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006273395 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11996854 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2006273395 Country of ref document: AU Date of ref document: 20060725 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0613979 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080125 |